Nosocomial COVID-19 Infection and Severe COVID-19 Pneumonia in Patients Hospitalized for Alcoholic Liver Disease: A Case Report

Wiśniewska H, Skowron M, Bander D, Hornung M, Jurczyk K, Karpińska E, Laurans Ł, Socha Ł, Czajkowski Z, Wawrzynowicz-Syczewska M.

Low risk of hepatitis b reactivation in patients with severe COVID-19 who receive immunosuppressive therapy

Rodríguez-Tajes S, Miralpeix A, Costa J, López-Suñé E, Laguno M, Pocurull A, Lens S, Mariño Z, Forns X.

Liver Injury in Liver Transplant Recipients with Coronavirus Disease 2019 (COVID-19): US Multicenter Experience

Rabiee A, Sadowski B, Adeniji N, Perumalswami P, Nguyen V, Moghe A, Latt N, Kumar S, Aloman C, Catana AM, Bloom PP, Chavin K, Carr RM, Dunn W, Chen V, Aby ES, Debes J, Dhanasekaran R; COLD Consortium.

Anakinra for COVID-19: how to interpret elevations in serum liver enzymes

Cavalli G, Dagna L.

COVID-19 and the liver: What do we know after six months of the pandemic?

Fierro NA.

SARS-CoV-2 infection in liver transplant recipients: collaboration in the time of COVID-19

Heimbach JK, Taner T.

Management of hepatitis C in children and adolescents during COVID-19 pandemic

Pokorska-Åšpiewak M, Åšpiewak M.

Mechanisms and consequences of COVID-19 associated liver injury: What can we affirm?

Brito CA, Barros FM, Lopes EP.

Treatments in Covid-19 patients with pre-existing metabolic dysfunction-associated fatty liver disease: A potential threat for drug-induced liver injury?

Ferron PJ, Gicquel T, Mégarbane B, Clément B, Fromenty B.

Hepatology and the "new reality" ushered in by the COVID-19 pandemic

Uribe M, Aquino-Matus J.

Covid-19 can mimic acute cholecystitis and is associated with the presence of viral RNA in the gallbladder wall

Balaphas A, Gkoufa K, Meyer J, Peloso A, Bornand A, McKee TA, Toso C, Popeskou SG.

Complicated COVID-19 in pregnancy: a case report with severe liver and coagulation dysfunction promptly improved by delivery

Ronnje L, Länsberg JK, Vikhareva O, Hansson SR, Herbst A, Zaigham M.

Liver injury in patients with COVID-19: clinical profiles, CT findings, the correlation of the severity with liver injury

Lei P, Zhang L, Han P, Zheng C, Tong Q, Shang H, Yang F, Hu Y, Li X, Song Y.

Clinical characteristics and risk factors for liver injury in COVID-19 patients in Wuhan

Zhang H, Liao YS, Gong J, Liu J, Zhang H.

A systematic review and meta-analysis of the COVID-19 associated liver injury

Wong YJ, Tan M, Zheng Q, Li W, Kumar R, Fock KM, Teo EK, Ang TL.

Liver Injury in COVID-19 Infection: A Systematic Review

Ghoda A, Ghoda M.

COVID-19 and liver injury: where do we stand?

Papadopoulos N, Vasileiadi S, Deutsch M.

Clinical characteristics of coronavirus disease 2019 patients complicated with liver injury

Wen M, Lu J, Xie Y.

Rationale for using a C-arm fluoroscope to deliver a kilovoltage radiotherapy treatment to COVID-19 patients

Roa D, Moyses H, Leon S, Hamrick B, Sarria GR, Li B, Tajima T, Necas A, Guzman C, Paucar O, Gonzales A, Challco R, Montoya M, Arqque Z, Gonzales A, Hernandez J.

Elevated Liver Enzymes in Patients with COVID-19: Look, but Not Too Hard

Moon AM, Barritt AS 4th.

Systemic inflammation as fuel for acute liver injury in COVID-19

Effenberger M, Grander C, Grabherr F, Griesmacher A, Ploner T, Hartig F, Bellmann-Weiler R, Joannidis M, Zoller H, Weiss G, Adolph TE, Tilg H.

Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study

Webb GJ, Marjot T, Cook JA, Aloman C, Armstrong MJ, Brenner EJ, Catana MA, Cargill T, Dhanasekaran R, García-Juárez I, Hagström H, Kennedy JM, Marshall A, Masson S, Mercer CJ, Perumalswami PV, Ruiz I, Thaker S, Ufere NN, Barnes E, Barritt AS 4th, Moon AM.

COVID-19 and Liver Injury: A Systematic Review and Meta-Analysis

Ahmed J, Rizwan T, Malik F, Akhter R, Malik M, Ahmad J, Khan AW, Chaudhary MA, Usman MS.

Carrying on with liver transplantation during the COVID-19 emergency: Report from piedmont region

Saracco M, Martini S, Tandoi F, Dell'Olio D, Ottobrelli A, Scarmozzino A, Amoroso A, Fonio P, Balagna R, Romagnoli R.

SARS-CoV-2 another kind of liver aggressor, how does it do that?

Lozano-Sepulveda SA, Galan-Huerta K, Martínez-Acuña N, Arellanos-Soto D, Rivas-Estilla AM.

Clinical characteristics of chronic liver disease with coronavirus disease 2019 (COVID-19): a cohort study in Wuhan, China

Li C, Chen Q, Wang J, Lin H, Lin Y, Lin J, Peng F, Chen J, Yang Z.

Hepatic manifestations of COVID-19

El Ouali S, Romero-Marrero C, Regueiro M.

Optimal multiparametric set-up modelled for best survival outcomes in palliative treatment of liver malignancies: unsupervised machine learning and 3 PM recommendations

Goldstein E, Yeghiazaryan K, Ahmad A, Giordano FA, Fröhlich H, Golubnitschaja O.

Impact of COVID-19 on the care of patients with liver disease: EASL-ESCMID position paper after 6 months of the pandemic

Boettler T, Marjot T, Newsome PN, Mondelli MU, Maticic M, Cordero E, Jalan R, Moreau R, Cornberg M, Berg T.

Gastrointestinal and liver involvement in patients with COVID-19

Barrera FJ, González-González JG, Rodríguez-Gutiérrez R.

Gastrointestinal and liver involvement in patients with COVID-19 - Authors' reply

Qiu Y, He JS, Tan JY, Lin SN, Mao R.

Gastrointestinal and liver involvement in patients with COVID-19

Xu Y, Liu P, Gu J.

Modulating immunosuppression in liver transplant patients with COVID-19

Rodriguez-Peralvarez M, Salcedo M, Colmenero J, Pons JA.

Reply to comment: Screening for active COVID-19 infection prior to biologic therapy in IBD patients: primum non nŏcēre

Zingone F, Buda A, Savarino E.

Clinical insight into the involvement of gut and liver by COVID-19

Abbas Z, Zaheer R.

Effect of common medications on the expression of SARS-CoV-2 entry receptors in liver tissue

Saheb Sharif-Askari N, Saheb Sharif-Askari F, Mdkhana B, Al Heialy S, Ratemi E, Alghamdi M, Abusnana S, Kashour T, Hamid Q, Halwani R.

Trinational Study Exploring the Early Impact of the COVID-19 Pandemic on Organ Donation and Liver Transplantation at National and Unit Levels

Reddy MS, Hakeem AR, Klair T, Marcon F, Mathur A, Samstein B, Mohanka R, Mathur SK, Prachalias A, Menon KV, Muiesan P, Rela M, Emond JC.

Poor outcomes in patients with cirrhosis and Corona Virus Disease-19

Shalimar, Elhence A, Vaishnav M, Kumar R, Pathak P, Soni KD, Aggarwal R, Soneja M, Jorwal P, Kumar A, Khanna P, Singh AK, Biswas A, Nischal N, Dar L, Choudhary A, Rangarajan K, Mohan A, Acharya P, Nayak B, Gunjan D, Saraya A, Mahapatra S, Makharia G, Trikha A, Garg P.

COVID-19 in Liver Transplant Patients: Report of 2 Cases and Review of the Literature

Niknam R, Malek-Hosseini SA, Hashemieh SS, Dehghani M.

Dealing With Liver Transplantation during Coronavirus Disease 2019 Pandemic: Normothermic Machine Perfusion Enables for Donor, Organ, and Recipient Assessment: A Case Report

Bogensperger C, Cardini B, Oberhuber R, Weissenbacher A, Gasteiger S, Berchtold V, Otarashvili G, Öfner D, Schneeberger S.

Liver injury in patients with severe acute respiratory syndrome coronavirus-2 infection: a systematic review and meta-analysis

Labenz C, Toenges G, Wörns MA, Sprinzl MF, Galle PR, Schattenberg JM.

Maintaining Patient Safety and Data Integrity of NASH Clinical Trials During the SARS-CoV-2 Pandemic

Alkhouri N, Kohli A, Loomba R, Harrison SA.

Relationship Between COVID-19 Infection and Liver Injury: A Review of Recent Data

Ali N.

Serum Activity of Liver Enzymes Is Associated With Higher Mortality in COVID-19: A Systematic Review and Meta-Analysis

Boregowda U, Aloysius MM, Perisetti A, Gajendran M, Bansal P, Goyal H.

Hepatic pathology in patients dying of COVID-19: a series of 40 cases including clinical, histologic, and virologic data

Lagana SM, Kudose S, Iuga AC, Lee MJ, Fazlollahi L, Remotti HE, Del Portillo A, De Michele S, de Gonzalez AK, Saqi A, Khairallah P, Chong AM, Park H, Uhlemann AC, Lefkowitch JH, Verna EC.

Liver abnormality may develop cerebral venous sinus thrombosis in COVID-19

Neshin SAS, Basirjafari S, Saberi A, Shahhosseini B, Zarei M.

Clinical outcomes of COVID-19 patients with chronic hepatitis B virus infection still need to be explored

Lv XH, Yang JL, Deng K.

Mild vs severe liver injury in SARS-CoV-2 infection

Anastasiou OE, Korth J, Herbstreit F, Witzke O, Lange CM.

Impact of COVID-19 on global hepatitis C elimination efforts

Blach S, Kondili LA, Aghemo A, Cai Z, Dugan E, Estes C, Gamkrelidze I, Ma S, Pawlotsky JM, Razavi-Shearer D, Razavi H, Waked I, Zeuzem S, Craxi A.

Significance of liver dysfunction associated with decreased hepatic CT attenuation values in Japanese patients with severe COVID-19

Uchida Y, Uemura H, Yamaba S, Hamada D, Tarumoto N, Maesaki S, Mochida S.

Hepatology in the COVID Era: Another C Virus, again Challenging the Liver

Peixe P, Calinas F, Tato Marinho R.

In-Person Outreach and Telemedicine in Liver and Intestinal Transplant: A Survey of National Practices, Impact of COVID-19 and Areas of Opportunity

Sherman CB, Said A, Kriss M, Potluri V, Levitsky J, Reese PP, Shea JA, Serper M.

Authors' reply on HIGH RATES OF 30-DAY MORTALITY IN PATIENTS WITH CIRRHOSIS AND COVID-19

Iavarone M, D'Ambrosio R, Lampertico P; CirCoV study group.

Liver transplantation and COVID-19: a case report and cross comparison between two identical twins with COVID-19

Nikoupour H, Arasteh P, Gholami S, Nikeghbalian S.

Abnormal liver-related biomarkers in COVID-19 patients and the role of prealbumin

Li T, Guo Y, Zhuang X, Huang L, Zhang X, Wei F, Yang B.

Letter to the Editors: Statins and COVID-19: Efficacy Still to Be Proven

Meunier L, Meszaros M, Pageaux GP.

Letter to the Editors: COVID-19-Related Liver Injury: The Interpretation for Aspartate Aminotransferase Needs to Be Cautious

Lv XH, Yang JL, Deng K.

In reply to Drs. Lv, Yang, and Deng

Bloom PP, Chung RT.

Liver function should be monitored when treating COVID-19 in chronic HBV-infected patients

Zou X, Fang M, Huang J.

Longitudinal Changes of Liver Function and Hepatitis B Reactivation in COVID-19 Patients with Pre-existing Chronic HBV Infection

Liu J, Wang T, Cai Q, Sun L, Huang D, Zhou G, He Q, Wang FS, Liu L, Chen J.

Comparison of virus concentration methods for the RT-qPCR-based recovery of murine hepatitis virus, a surrogate for SARS-CoV-2 from untreated wastewater

Ahmed W, Bertsch PM, Bivins A, Bibby K, Farkas K, Gathercole A, Haramoto E, Gyawali P, Korajkic A, McMinn BR, Mueller JF, Simpson SL, Smith WJM, Symonds EM, Thomas KV, Verhagen R, Kitajima M.

How Patients With Chronic Liver Diseases Succeed to Deal With COVID-19?

Rezasoltani S, Hatami B, Yadegar A, Asadzadeh Aghdaei H, Zali MR.

Liver injury in COVID-19: What do we know now?

Yang HY, Jin B, Mao YL.

Epidemiological pattern, incidence and outcomes of COVID-19 in liver transplant patients

Colmenero J, Rodríguez-Perálvarez M, Salcedo M, Arias-Milla A, Muñoz-Serrano A, Graus J, Nuño J, Gastaca M, Bustamante-Schneider J, Cachero A, Lladó L, Caballero A, Fernández-Yunquera A, Loinaz C, Fernández I, Fondevilla C, Navasa M, Iñarrairaegui M, Castells L, Pascual S, Ramírez P, Vinaixa C, González-Dieguez ML, González-Grande R, Hierro L, Nogueras F, Otero A, Álamo JM, Blanco-Fernández G, Fábrega E, García-Pajares F, Montero JL, Tomé S, De la Rosa G, Pons JA.

[Guidance on the special care of liver or kidney transplant recipients diagnosed with COVID-19]

Remport Á, Gerlei Z, Cseprekál O, Wagner L, Földes K, Marton A, Patonai A, Török S, Haboub-Sandil A, Varga M, Doros A, Smudla A, Fazakas J, Kóbori L.

How endoscopy centers prepare to reopen after the acute COVID-19 pandemic interruption of activity

Castagna V, Armellini E, Pace F; Fast Track Endoscopy Study Group.

Profiles of liver function abnormalities in elderly patients with Coronavirus Disease 2019

Yu X, He W, Wang L, Bao M, Liu H, Zhou J, Jiang H.

Severe COVID-19 patients with liver injury: a seven-case series

Li X, Zhang ZC, Zhang PL.

Noninvasive monitoring of inflammatory bowel disease in the post COVID-19 era

Nardone OM, Rispo A, Castiglione F.

Clinical Research in Hepatology in the COVID-19 Pandemic and Post-Pandemic Era: Challenges and the Need for Innovation

Verna EC, Serper M, Chu J, Corey K, Fix OK, Hoyt K, Page KA, Loomba R, Li M, Everson GT, Fried MW, Garcia-Tsao G, Terrault N, Lok AS, Chung RT, Reddy KR.

COVID-19 Lockdown: Impact on Liver Transplant Recipients- A Single Centre Survey

Jothimani D, Daniel H, Danielraj S, Ramachandran H, Rela M.

Prevalence of Abnormal Liver Function Tests in COVID-19 Patients at a Tertiary Care Centre

Kaushik A, Wani SN, Baba MA, Agarwal AK.

Effect of COVID-19 on patients with compensated chronic liver diseases

Ji D, Zhang D, Yang T, Mu J, Zhao P, Xu J, Li C, Cheng G, Wang Y, Chen Z, Qin E, Lau G.

Strengthening vaccine confidence during the COVID-19 pandemic: A new opportunity for global hepatitis B virus elimination

Lazarus JV, Picchio CA, Nayagam S, Ratzan S, Thursz M.

The Antiviral Properties of Cyclosporine. Focus on Coronavirus, Hepatitis C Virus, Influenza Virus, and Human Immunodeficiency Virus Infections

Glowacka P, Rudnicka L, Warszawik-Hendzel O, Sikora M, Goldust M, Gajda P, Stochmal A, Blicharz L, Rakowska A, Olszewska M.

Estimating Shortages in Capacity to Deliver Continuous Kidney Replacement Therapy During the COVID-19 Pandemic in the United States

Reddy YNV, Walensky RP, Mendu ML, Green N, Reddy KP.

Eliminating viral hepatitis in the COVID-19 era: weighing challenge and opportunity

The Lancet Gastroenterology Hepatology.

The impact of COVID-19 on hepatitis elimination

Wingrove C, Ferrier L, James C, Wang S.

Time-dependent changes in the seroprevalence of COVID-19 in asymptomatic liver disease outpatients in an area in Japan undergoing a second wave of COVID-19

Suda G, Ogawa K, Kimura M, Maehara O, Kitagataya T, Ohara M, Tokuchi Y, Kubo A, Yamada R, Shigesawa T, Suzuki K, Kawagishi N, Nakai M, Sho T, Natsuizaka M, Morikawa K, Sakamoto N.

Hepatology Consultants Often Disagree on Etiology of Abnormal Liver Biochemistries in COVID-19 but Agree on Management

Bloom PP, Pasricha TS, Andersson KL, Pratt DS, Hashemi N, Bhan I, Viveiros K.

COVID-19 and liver disease: An update

Téllez L, Martín Mateos RM.

Abnormal Liver Tests in COVID-19: A Retrospective Observational Cohort Study of 1827 Patients in a Major U.S. Hospital Network

Hundt MA, Deng Y, Ciarleglio MM, Nathanson MH, Lim JK.

Liver injury in remdesivir-treated COVID-19 patients

Zampino R, Mele F, Florio LL, Bertolino L, Andini R, Galdo M, De Rosa R, Corcione A, Durante-Mangoni E.

Prevalence of chronic liver disease in patients with COVID-19 and their clinical outcomes: a systematic review and meta-analysis

Kovalic AJ, Satapathy SK, Thuluvath PJ.

COVID-19 induced liver function abnormality associates with age

Li S, Li J, Zhang Z, Tan L, Shao T, Li M, Li X, Holmes JA, Lin W, Han M.

Hepatic disorders with the use of remdesivir for coronavirus 2019 (COVID-19)

Montastruc F, Thuriot S, Durrieu G.

Collateral Effect of COVID-19 Pandemic on Hospitalizations and Clinical Outcomes in Gastrointestinal and Liver Diseases - A Territory-wide Observational Study in Hong Kong

Lau LH, Wong SH, Yip TC, Wong GL, Wong VW, Sung JJ.

Hepatitis A susceptibility parallels high COVID-19 mortality

SarialİoĞlu F, Belen FB, Hayran KM.

Digestive and Liver Diseases and the COVID-19 Pandemic

de Franchis R.

Liver damage at admission is an independent prognostic factor for COVID-19

Chen LY, Chu HK, Bai T, Tu SJ, Wei Y, Li ZL, Hu LL, Zhu R, Zhang L, Han CQ, Xiao L, He Q, Song J, Liu WH, Zhu QJ, Chen H, Yang L, Hou XH.

Incidence, risk factors, and prognosis of abnormal liver biochemical tests in COVID-19 patients: a systematic review and meta-analysis

Wu Y, Li H, Guo X, Yoshida EM, Mendez-Sanchez N, Levi Sandri GB, Teschke R, Romeiro FG, Shukla A, Qi X.

The impact of COVID policies on the vitreoretinal service in St Paul's Eye Unit, Liverpool

Dervenis N, Heimann H, Hussain RN, Chua PY, Sandinha T, Vilà N, Pearce I, Groenewald C, Tan SZ.

Assessing the impact of COVID-19 on the management of patients with liver diseases: A national survey by the Italian association for the study of the Liver

Aghemo A, Masarone M, Montagnese S, Petta S, Ponziani FR, Russo FP; Associazione Italiana Studio Fegato (AISF).

Will "Video kill the Radiostar" or is zooming just a pandemic transient Hype? Some cautionary notes

Macedo G.

SARS-CoV-2 infection in severe pediatric Crohn's disease. What about anti-tumor necrosis factor α therapy?

Giulia B, Patrizia A.

Insights in the approach of long-term liver transplant recipients with COVID-19

Terrabuio DRB, Haddad L, Ducatti L, Gouveia L, Rocha-Santos V, Ferreira RMT, Darce GF, Cardoso AJA, Carrilho FJ, Andraus W, Abdala E, D Albuquerque LAC.

Abnormal liver function tests in COVID-19 patients: relevance and potential pathogenesis

Bertolini A, van de Peppel IP, Bodewes FAJA, Moshage H, Fantin A, Farinati F, Fiorotto R, Jonker JW, Strazzabosco M, Verkade HJ, Peserico G.

The association between markers of liver injury and clinical outcomes in patients with COVID-19 in Wuhan

Huang H, Chen S, Li H, Zhou XL, Dai Y, Jia W, Zhang J, Shao L, Yan R, Wang M, Wang J, Tu Y, Ge M.

Elevated Liver Biochemistries in Hospitalized Chinese Patients with Severe COVID-19: Systematic Review and Meta-analysis

Kovalic AJ, Huang G, Thuluvath PJ, Satapathy SK.

Diagnostic challenges of incidental lung lesions on liver MRI during the COVID-19 pandemic

Deen SS, Wetscherek M, Karia S, Godfrey EM.

Reorganization of the functional gastrointestinal disorders unit during the SARS-CoV-2 outbreak - Practical Recommendations

Ghisa M, Barberio B, Lorenzon G, Zingone F, Savarino E.

Children and Fecal SARS-CoV-2 shedding: Just the tip of the Iceberg of Italian COVID-19 outbreak?

Oliva S, Cucchiara S, Locatelli F.

Higher frequency of hepatic steatosis at CT among COVID-19-positive patients

Medeiros AK, Barbisan CC, Cruz IR, de Ara√∫jo EM, Lib√¢nio BB, Albuquerque KS, Torres US.

Acute on Chronic Liver Failure - Possibly the main culprit of increased mortality in COVID-19 patients with liver disease

Khan MU, Mushtaq K, Alkaabi SR.

Prevalence of functional gastrointestinal disorders in children with celiac disease during the COVID-19 lockdown

Nastro FF, Tolone C, Serra MR, Pacella D, Campanozzi A, Strisciuglio C.

Trends in cirrhosis hospitalizations during the COVID-19 pandemic

Gaspar R, Liberal R, Branco CC, Macedo G.

Running out of bullets: the challenging management of acute hepatitis and SARS-COV-2 from the SMatteo COvid19 Registry (SMACORE)

Colaneri M, Valsecchi P, Perotti L, Ludovisi S, Seminari E, Chiara Pieri T, Sacchi P, Bruno R.

Alcohol related liver disease and Covid-19 emergency: interaction between hepatologist and primary care physician

Testino G, Adriani A.

Value-based medicine, a compass to guide health care decisions in the COVID-19 aftermath

Strazzabosco M.

Alteration of Liver Biomarkers in Patients with SARS-CoV-2 (COVID-19)

Gholizadeh P, Safari R, Marofi P, Zeinalzadeh E, Pagliano P, Ganbarov K, Esposito S, Khodadadi E, Yousefi M, Samadi Kafil H.

Involvement of liver in COVID-19: systematic review and meta-analysis

Yadav DK, Singh A, Zhang Q, Bai X, Zhang W, Yadav RK, Singh A, Zhiwei L, Adhikari VP, Liang T.

Liver Transplant Recipients Infected with SARS-CoV-2 in the Early Postoperative Period: Lessons from a Single Center in the Epicenter of the Pandemic

Waisberg DR, Abdala E, Nacif LS, Haddad LB, Ducatti L, Rocha-Santos V, Gouveia LN, Lazari CS, Martino RB, Pinheiro RS, Arantes RM, Terrabuio DR, Malbouisson LM, Galvao FH, Andraus W, Carneiro-D Albuquerque LA.

COVID-19, liver transplant and immunosuppression: allies or foes?

Parente A, Manzia TM, Angelico R, Tirotta F, Muiesan P, Tisone G, Framarino Dei Malatesta M.

Liver stiffness by transient elastography accompanies illness severity in COVID-19

Effenberger M, Grander C, Fritsche G, Bellmann-Weiler R, Hartig F, Wildner S, Seiwald S, Adolph TE, Zoller H, Weiss G, Tilg H.

Awareness And Concerns About Novel Coronavirus Disease 2019 (COVID-19) Among Parents Of Pediatric Liver Transplant Recipients

Menon J, Shanmugam N, Patel K, Hakeem A, Srinivas Reddy M, Rela M.

Safety, pharmacokinetics, and activity of high-dose ivermectin and chloroquine against the liver-stage of Plasmodium cynomolgi infection in Rhesus Macaques

Vanachayangkul P, Im-Erbsin R, Tungtaeng A, Kodchakorn C, Roth A, Adams J, Chaisatit C, Saingam P, Sciotti RJ, Reichard GA, Nolan CK, Pybus BS, Black CC, Lugo-Roman LA, Wegner MD, Smith PL, Wojnarski M, Vesely BA, Kobylinski KC.

Comparison of mortality risk in patients with cirrhosis and COVID-19 compared with patients with cirrhosis alone and COVID-19 alone: multicentre matched cohort

Bajaj JS, Garcia-Tsao G, Biggins S, Kamath PS, Wong F, McGeorge S, Shaw J, Pearson M, Chew M, Fagan A, de la Rosa Rodriguez R, Worthington J, Olofson A, Weir V, Trisolini C, Dwyer S, Reddy KR.

[Research progress on the clinical features and mechanisms of COVID-19 combined with liver injury]

Xie YB, Wang SY, Zhang C, Wang FS.

The Impacts of the COVID-19 Pandemic on Liver Transplant Patients; Time to Change the Priorities

Dooghaie Moghadam A, Eslami P, Razavi-Khorasani N, Moazzami B, Mousavizadeh M, Zali MR, Sadeghi A.

Letter: liver disease and COVID-19-not the perfect storm. Authors' reply"

Garrido I, Liberal R, Macedo G.

Letter: liver disease and COVID-19-not the perfect storm

Nathwani R, Mukherjee S, Forlano R, Mullish BH, Vergis N, Selvapatt N, Manousou P, Nayagam S, Lemoine M, Dhar A.

Roadmap to Resuming Care for Liver Diseases after COVID-19

Kapuria D, Bollipo S, Rabiee A, Ben Yakov G, Kumar G, Siau K, Lee HW, Congly S, Turnes J, Dhanasekaran R, Lui RN; Global Online Alliance for Liver Studies (GOAL).

Liver Injury in Critically Ill and Non-critically Ill COVID-19 Patients: A Multicenter, Retrospective, Observational Study

Jiang S, Wang R, Li L, Hong D, Ru R, Rao Y, Miao J, Chen N, Wu X, Ye Z, Hu Y, Xie M, Zuo M, Lu X, Qiu Y, Liang T.

The Impact of COVID-19 Global Pandemic on Morbidity and Mortality of Liver Transplant Recipients Children and Adults: A Systematic Review of Case Series

Gavriilidis P, Pai M.

Liver histopathology in severe COVID 19 respiratory failure is suggestive of vascular alterations

Sonzogni A, Previtali G, Seghezzi M, Alessio MG, Gianatti A, Licini L, Morotti D, Zerbi P, Carsana L, Rossi R, Laur E, Pellegrinelli A, Nebuloni M.

"Perioperative Presentation of COVID-19 Disease in a Liver Transplant Recipient"

Reiberger T, Mandorfer M.

Surveillance and Monitoring of Hepatocellular Carcinoma During the COVID-19 Pandemic

Mehta N, Parikh N, Kelley RK, Hameed B, Singal AG.

Impact of COVID-19 on liver function: results from an internal medicine unit in Northern Italy

Lenti MV, Borrelli de Andreis F, Pellegrino I, Klersy C, Merli S, Miceli E, Aronico N, Mengoli C, Di Stefano M, Cococcia S, Santacroce G, Soriano S, Melazzini F, Delliponti M, Baldanti F, Triarico A, Corazza GR, Pinzani M, Di Sabatino A; Internal Medicine Covid-19 Team.

COVID-19 and liver transplantation

Di Maira T, Berenguer M.

Successful urgent liver transplant due to fulminant autoimmune hepatitis during the height of the COVID-19 pandemic in Spain

Rodríguez-Gandía MA, López-Hervás P, Téllez L, Gajate L; en nombre de la Unidad de Trasplante Hepático.

Suspension of ulipristal acetate for uterine fibroids during ongoing EMA's review of liver injury risk: Unfortunate timing during the Covid-19 pandemic!

Rozenberg S, Revercez P, Fastrez M, Vandromme J, Bucella D.

Liver injury in severe COVID-19 infection: current insights and challenges

Ali N, Hossain K.

Patients with COVID-19 present with low plasma citrulline concentrations that associate with systemic inflammation and gastrointestinal symptoms

Uzzan M, Soudan D, Peoch K, Weiss E, Corcos O, Treton X.

Unchanged surgical management of patients with Cholangiocarcinoma during the COVID-19 pandemic

Gringeri E, Gambato M, Furlanetto A, Ballo M, Nieddu E, Cillo U.

Liver transplant immunosuppression during the covid-19 pandemic

Forns X, Navasa M.

Inflammasome Activation and Pyroptosis in Lymphopenic COVID-19 Liver Patients

Kroemer A, Khan K, Plassmeyer M, Alpan O, Haseeb MA, Gupta R, Fishbein TM.

Predictor of poor prognosis of COVID-19 patients----liver injury

Fu T, Deng M, Wang X, Yang F.

Liver injury is independently associated with adverse clinical outcomes in patients with COVID-19

Yip TC, Lui GC, Wong VW, Chow VC, Ho TH, Li TC, Tse YK, Hui DS, Chan HL, Wong GL.

Acute immune thrombocytopaenic purpura in a patient with COVID-19 and decompensated cirrhosis

Artru F, Alberio L, Moradpour D, Stalder G.

Prevalence of acute liver injury and hypertransaminemia in patients with COVID-19: a protocol for a systematic review

Li G, Xu Y, Yang YT, Liu PF.

COVID-19-related thrombotic microangiopathy in a cirrhotic patient

Airoldi A, Perricone G, De Nicola S, Molisano C, Tarsia P, Belli LS.

COVID-19 and liver injury: a meta-analysis

Wijarnpreecha K, Ungprasert P, Panjawatanan P, Harnois DM, Zaver HB, Ahmed A, Kim D.

COVID-19: an emergent cause of liver injury?

Cadranel JF, Reboux N, Nousbaum JB.

Systematic review with meta-analysis: liver manifestations and outcomes in COVID-19

Kulkarni AV, Kumar P, Tevethia HV, Premkumar M, Arab JP, Candia R, Talukdar R, Sharma M, Qi X, Rao PN, Reddy DN.

Bilio-pancreatic endoscopy during COVID-19 pandemic

Bove V, Schepis T, Boškoski I, Landi R, Orlandini B, Pontecorvi V, Familiari P, Tringali A, Perri V, Costamagna G.

Who comes first: Rescheduling endoscopic activity after the acute phase of the Covid 19 pandemic

Tripodi G, Dilaghi E, Fanella S, Corleto VD, Giulio ED; Endoscopy prioritization group.

Reply to "Liver tests abnormalities in COVID-19: trick or treat?"

Cai Q, Xu L, Chen J.

Liver involvement is not associated with mortality: results from a large cohort of SARS-CoV-2 positive patients

Romana Ponziani F, Del Zompo F, Nesci A, Santopaolo F, Ianiro G, Pompili M, Gasbarrini A; “Gemelli against COVID-19” group.

Coronavirus disease (COVID-19) and the liver: a comprehensive systematic review and meta-analysis

Kumar-M P, Mishra S, Jha DK, Shukla J, Choudhury A, Mohindra R, Mandavdhare HS, Dutta U, Sharma V.

Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study)

Sarin SK, Choudhury A, Lau GK, Zheng MH, Ji D, Abd-Elsalam S, Hwang J, Qi X, Cua IH, Suh JI, Park JG, Putcharoen O, Kaewdech A, Piratvisuth T, Treeprasertsuk S, Park S, Wejnaruemarn S, Payawal DA, Baatarkhuu O, Ahn SH, Yeo CD, Alonzo UR, Chinbayar T, Loho IM, Yokosuka O, Jafri W, Tan S, Soo LI, Tanwandee T, Gani R, Anand L, Esmail ES, Khalaf M, Alam S, Lin CY, Chuang WL, Soin AS, Garg HK, Kalista K, Batsukh B, Purnomo HD, Dara VP, Rathi P, Al Mahtab M, Shukla A, Sharma MK, Omata M; APASL COVID T

Telemedicine Platforms and Their Use in the Coronavirus Disease-19 Era to Deliver Comprehensive Vascular Care

Lin JC, Humphries MD, Shutze WP, Aalami OO, Fischer UM, Hodgson KJ.

A brief review of liver injury in patients with Corona Virus Disease-19 during the pandemic

Farshidpour M, Kim D, Junna S, Merchant J.

Deceased Donor Liver Transplantation in India in the COVID-19 Era: Current Scenario and Future Perspectives

Pahari H, Shellagi N, Nath B.

Pharmacologic management of patients with hepatic and pancreatic diseases that involve immunosuppressive therapies. Positioning within the framework of the SARS-CoV-2 (COVID-19) pandemic

Miranda-Zazueta G, González-Regueiro JA, García-Juárez I, Moctezuma-Velázquez C, López-Díaz FJ, Pérez-González B, Uscanga-Domínguez LF, Peláez-Luna M.

Letter to the Editors: Additional Factors to Consider When Studying Liver Injury Indicators and Mortality in COVID-19 Patients

Liu Y.

Letter to the Editor: COVID-19-Related Liver Injury and Clinical Outcomes: Does It Really Exist?

Philips CA, Ahamed R, Augustine P.

Liver Enzyme Elevation in Coronavirus Disease 2019: A Multicenter, Retrospective, Cross-Sectional Study

Hao SR, Zhang SY, Lian JS, Jin X, Ye CY, Cai H, Zhang XL, Hu JH, Zheng L, Zhang YM, Jia HY, Yu GD, Wang XY, Gu JQ, Lu YF, Yu XP, Yu L, Xiang DR, Ye CY, Jin CL, Qiu YQ, Li LJ, Sheng JF, Liang TB, Yang YD.

Fatal COVID-19 in a Patient with End-Stage Liver Disease Wait-Listed for Liver Transplantation: An Evidence-Based Review of COVID-19 Screening Modalities Prior to Transplant

Rhee Y, Chan EL, Eswaran SL, Aloman C, Hertl M, Santos CAQ.

Histopathological findings in a COVID-19 patient affected by ischemic gangrenous cholecystitis

Bruni A, Garofalo E, Zuccalà V, Currò G, Torti C, Navarra G, De Sarro G, Navalesi P, Longhini F, Ammendola M.

Reduced rate of hospital admissions for liver-related morbidities during the initial COVID-19 outbreak

Eshraghian A, Taghavi A, Nikeghbalian S, Malek-Hosseini SA.

Impact of the SARS-CoV-2 outbreak on pediatric liver transplant recipients residing in Lombardy, Northern Italy

Nicastro E, Di Giorgio A, Zambelli M, Ginammi M, Bravi M, Stroppa P, Casotti V, Palladino R, Colledan M, D'Antiga L.

Reply to Letter to the Editor: COVID-19-Related Liver Injury and Clinical Outcomes: Does It Really Exist?

Lei F, Liu YM, Zhou F, Qin JJ, Huang X, Zhang BH, Li H, Yuan Y.

The New Virtual Reality: How COVID-19 Will Affect the Gastroenterology and Hepatology Fellowship Match

Mallepally N, Bilal M, Hernandez-Barco YG, Simons M, Berzin TM, Oxentenko AS.

Impact of COVID-19 on liver transplantation in Europe: Alert from an early survey of European Liver and Intestine Transplantation Association (ELITA) and European Liver Transplant Registry (ELTR)

Polak WG, Fondevila C, Karam V, Adam R, Baumann U, Germani G, Nadalin S, Taimr P, Toso C, Troisi RI, Zieniewicz K, Belli LS, Duvoux C; European Liver, Intestine Transplant Association (ELITA).

Planning phase two for endoscopic units in Northern Italy after the COVID-19 lockdown: An exit strategy with a lot of critical issues and a few opportunities

Manes G, Repici A, Radaelli F, Bezzio C, Colombo M, Saibeni S.

The forgotten victims of the COVID-19 pandemic

Benites-Goñi H, Alférez-Andía J, Barreda-Bolaños F.

Liver transplantation during the COVID-19 epidemic : recommendations from the Belgian Liver Intestine Transplant Committee (BeLIAC)

Dahlqvist G, Ciccarelli O, Van Vlierberghe H, Berrevoet F, Vanwolleghem T, Ysebaert D, Gustot T, Lucidi V, Delwaide J, Detry O, Delbouille MH, Sokal E, Nevens F, Pirenne J.

Clinical Features of COVID-19-Infected Patients With Elevated Liver Biochemistries: A Multicenter, Retrospective Study

Fu Y, Zhu R, Bai T, Han P, He Q, Jing M, Xiong X, Zhao X, Quan R, Chen C, Zhang Y, Tao M, Yi J, Tian D, Yan W.

Critically ill patients with COVID-19 with ECMO and artificial liver plasma exchange: A retrospective study

Liu J, Dong YQ, Yin J, He G, Wu X, Li J, Qiu Y, He X.

COVID-19 and nonalcoholic fatty liver disease: two intersecting pandemics

Portincasa P, Krawczyk M, Smyk W, Lammert F, Di Ciaula A.

Patterns of liver injury in COVID-19 - a German case series

Schattenberg JM, Labenz C, Wörns MA, Menge P, Weinmann A, Galle PR, Sprinzl MF.

COVID-19 pandemic: Its impact on liver disease and liver transplantation

Sahin TT, Akbulut S, Yilmaz S.

Challenges for Liver Transplantation During Recovery From the COVID-19 Pandemic: Insights and Recommendations

Niriella MA, Siriwardana RC, Perera MTPR, Narasimhan G, Chan SC, Dassanayake AS.

Hepatocellular Type II Fibrinogen Inclusions in a Patient with Severe COVID-19 and Hepatitis

Fraga M, Moradpour D, Artru F, Romailler E, Tschopp J, Schneider A, Chtioui H, Neerman-Arbez M, Casini A, Alberio L, Sempoux C.

Management of patients with liver derangement during the COVID-19 pandemic: an Asia-Pacific position statement

Wong GL, Wong VW, Thompson A, Jia J, Hou J, Lesmana CRA, Susilo A, Tanaka Y, Chan WK, Gane E, Ong-Go AK, Lim SG, Ahn SH, Yu ML, Piratvisuth T, Chan HL; Asia-Pacific Working Group for Liver Derangement during the COVID-19 Pandemic.

Impact of Chronic Liver Disease on Outcomes of Hospitalized Patients with COVID-19: A Multicenter United States Experience

Hashemi N, Viveiros K, Redd WD, Zhou JC, McCarty TR, Bazarbashi AN, Hathorn KE, Wong D, Njie C, Shen L, Chan WW.

Treatment of Hepatocellular Carcinoma (HCC) during the COVID-19 Outbreak: The Working Group Report of JAMTT-HCC

Kudo M, Kurosaki M, Ikeda M, Aikata H, Hiraoka A, Torimura T, Sakamoto N; Japan Association of Molecular Targeted Therapy for HCC (JAMTT-HCC).

Challenges in Abdominal Organ Transplantation During the COVID-19 Pandemic

Esagian SM, Ziogas IA, Giannis D, Hayat MH, Elias N, Tsoulfas G.

Hepatic manifestations and complications of COVID-19: A systematic review and meta-analysis

Kunutsor SK, Laukkanen JA.

The impact of COVID-19 on the clinical outcome of patients with cirrhosis deserves more attention and research

Gao F, Huang ZM.

Is the increased risk for MAFLD patients to develop severe COVID-19 linked to perturbation of the gut-liver axis?

Assante G, Williams R, Youngson NA.

Letter regarding [High rates of 30-day mortality in patients with cirrhosis and COVID-19]

Medhat MA, El Kassas M.

Effect of COVID-19 on liver transplantation in KOREA

Lee JM.

Virtual empathy and liver cancer

Debes JD.

Metabolic associated fatty liver disease is associated with severity of COVID-19

Zhou YJ, Zheng KI, Wang XB, Sun QF, Pan KH, Wang TY, Ma HL, Chen YP, George J, Zheng MH.

Clinical epidemiological analyses of overweight/obesity and abnormal liver function contributing to prolonged hospitalization in patients infected with COVID-19

Hu X, Pan X, Zhou W, Gu X, Shen F, Yang B, Hu Z.

Risk factors in patients with COVID-19 developing severe liver injury during hospitalisation

Zhan K, Liao S, Li J, Bai Y, Lv L, Yu K, Qiu L, Li C, Yuan G, Zhang A, Mei Z.

COVID-19 in an international European liver transplant recipient cohort

Becchetti C, Zambelli MF, Pasulo L, Donato MF, Invernizzi F, Detry O, Dahlqvist G, Ciccarelli O, Morelli MC, Fraga M, Svegliati-Baroni G, van Vlierberghe H, Coenraad MJ, Romero MC, de Gottardi A, Toniutto P, Del Prete L, Abbati C, Samuel D, Pirenne J, Nevens F, Dufour JF; COVID-LT group.

Returning to digestive endoscopy normality will be slow and must include novelty and telemedicine

Koulaouzidis A, Marlicz W, Wenzek H, Koulaouzidis G, Eliakim R, Toth E.

COVID-19 with acute cholecystitis: a case report

Ying M, Lu B, Pan J, Lu G, Zhou S, Wang D, Li L, Shen J, Shu J; From the COVID-19 Investigating and Research Team.

Management of liver diseases during the pandemic of coronavirus disease-19

Cho JY, Kim SS, Lee YS, Song DS, Lee JH, Kim JH; Korean Association for the Study of the Liver.

Characteristics of pregnant COVID-19 patients with liver injury

Deng G, Zeng F, Zhang L, Chen H, Chen X, Yin M.

Case series and review of liver dysfunction in COVID-19 patients

Kudaravalli P, Saleem SA, Ibeche B, John S.

Caught in the crossfire: hepato-bilio-pancreatic cancer surgery in the midst of COVID-19

Rompianesi G, Shankar S, Reddy S, Silva M, Soonawalla Z, Friend PJ.

COVID-19 in gastroenterology and hepatology: Living with the realities of a historic 21(st) century pandemic

Yoshida EM, Hussaini T, Alsahafi M.

Decreased serum albumin level indicates poor prognosis of COVID-19 patients: hepatic injury analysis from 2,623 hospitalized cases

Huang W, Li C, Wang Z, Wang H, Zhou N, Jiang J, Ni L, Zhang XA, Wang DW.

Clinical characteristics and management of a liver transplanted patient admitted with SARS-CoV-2 infection

De Gottardi A, Fratila C, Bertoli R, Cerny A, Magenta L, Gianella P, Majno-Hurst P, Ceschi A, Vanini G, Bernasconi E.

Delivery of hepato-pancreato-biliary surgery during the COVID-19 pandemic: an European-African Hepato-Pancreato-Biliary Association (E-AHPBA) cross-sectional survey

Balakrishnan A, Lesurtel M, Siriwardena AK, Heinrich S, Serrablo A, Besselink MGH, Erkan M, Andersson B, Polak WG, Laurenzi A, Olde Damink SWM, Berrevoet F, Frigerio I, Ramia JM, Gallagher TK, Warner S, Shrikhande SV, Adam R, Smith MD, Conlon KC; E-AHPBA Scientific and Research Committee.

Principles of Care for Patients with Liver Disease During the Coronavirus Disease 2019 (COVID-19) Pandemic: Position Statement of the Saudi Association for the Study of Liver Disease and Transplantation

Alqahtani SA, Aljumah AA, Hashim A, Alenazi TH, AlJawad M, Al Hamoudi WK, Alghamdi MY.

Elevation of liver fibrosis index FIB-4 is associated with poor clinical outcomes in patients with COVID-19

Ibáñez-Samaniego L, Bighelli F, Usón C, Caravaca C, Carrillo CF, Romero M, Barreales M, Perelló C, Madejón A, Marcos AC, Albillos A, Fernández I, García-Samaniego J, Calleja JL, Bañares R.

Clinically significant portal hypertension in cirrhosis patients with COVID-19: clinical characteristics and outcomes

Liu F, Long X, Ji G, Zhang B, Zhang W, Zhang Z, Chen X.

Varied clinical presentation and outcome of SARS-CoV-2 infection in liver transplant recipients: initial experience at a single center in Madrid, Spain

Loinaz C, Marcacuzco A, Fernández-Ruiz M, Caso O, Cambra F, San Juan R, Justo I, Calvo J, García-Sesma A, Manrique A, Pérez-Jacoiste Asín MA, Folgueira MD, Aguado JM, Lumbreras C.

Five recommendations for loco-regional treatments of hepatocellular carcinoma during the COVID-19 pandemic

Santambrogio R, Galfrascoli E, Zappa MA.

Negative-pressure box under continuous suction for shielding against aerosols produced by patients with COVID-19 during abdominal ultrasound-guided intervention

Tani J, Kobara H, Nishiyama N, Masaki T.

From the liver ICU to the COVID ICU: The story of a transformation

Fern√°ndez J; en nombre de todo el equipo de la UCI Hep√°tica.

A case series of COVID-19 patients with chronic hepatitis B virus infection

Li Y, Li C, Wang J, Zhu C, Zhu L, Ji F, Liu L, Xu T, Zhang B, Xue L, Yan X, Huang R, Wu C, Yan X.

COVID-19 and the liver: overview

Amin M.

Covid-19 infection, liver injury and prognosis: a suggestion

Testino G.

Author response to Letter to the Editor: Potential implications of COVID-19 in non-alcoholic fatty liver disease

Xu L, Liu J, Lu M, Yang D, Zheng X.

Characteristics of liver function in patients with SARS-CoV-2 and chronic HBV co-infection

Zou X, Fang M, Li S, Wu L, Gao B, Gao H, Ran X, YiBian, Li R, Yu S, Ling J, Li D, Tian D, Huang J.

Clinical features and outcomes of coronavirus disease 2019 (COVID-19) patients with chronic Hepatitis B virus infection

Zhang B, Huang W, Zhang S.

Hepatic manifestations and impact of COVID-19 on the cirrhotic patient

Velarde-Ruiz Velasco JA, García-Jiménez ES, Remes-Troche JM.

Impact of Pre-existing Chronic Liver Disease on the Outcome of Patients with COVID-19 Disease

Verma N, Duseja A, Singh V.

COVID-19 pandemic perception in adults with celiac disease: an impulse to implement the use of telemedicine

Siniscalchi M, Zingone F, Savarino EV, D'Odorico A, Ciacci C.

Delivery of care remotely through telemedicine in celiac disease: Thinking beyond COVID-19: Commentary on: DLD-20-556R1 "COVID-19 pandemic perception in adults with celiac disease: an impulse to implement the use of telemedicine" by Siniscalchi M et al

Ines Pinto-Sanchez M, Lebwohl B.

COVID-19 and Liver

Jothimani D, Venugopal R, Abedin MF, Kaliamoorthy I, Rela M.

Converging pandemics: implications of COVID-19 for the viral hepatitis response in sub-Saharan Africa

Gupta N, Desalegn H, Ocama P, Lacombe K, Njouom R, Afihene M, Cunha L, Spearman CW, Sonderup MW, Kateera F.

Drinking alone: COVID-19, lockdown, and alcohol-related harm

The Lancet Gastroenterology Hepatology.

Pathological Findings of Postmortem Biopsies From Lung, Heart, and Liver of 7 Deceased COVID-19 Patients

Beigmohammadi MT, Jahanbin B, Safaei M, Amoozadeh L, Khoshavi M, Mehrtash V, Jafarzadeh B, Abdollahi A.

Subtotal laparoscopic cholecystectomy for gangrenous gallbladder during recovery from COVID-19 pneumonia

Lovece A, Asti E, Bruni B, Bonavina L.

COVID-19 Induced Hepatitis B Virus Reactivation: A Novel Case From the United Arab Emirates

Aldhaleei WA, Alnuaimi A, Bhagavathula AS.

Effective Use of Virtual Gamification During COVID-19 to Deliver the OB-GYN Core Curriculum in an Emergency Medicine Resident Conference

O'Connell A, Tomaselli PJ, Stobart-Gallagher M.

Liver injury without liver failure in COVID-19 patients: how to explain, in some cases, elevated ammonia without hepatic decompensation

Honore PM, Barreto Gutierrez L, Kugener L, Redant S, Attou R, Gallerani A, De Bels D.

COVID-19 in a patient with severe asthma treated with Omalizumab

Lommatzsch M, Stoll P, Christian Virchow J.

COVID 19 infection requires strengthening of the chronic care model: the impact on liver transplant practice at a high-volume center in Italy

De Simone P, Melandro F, Balzano E, Tincani G, Catalano G, Ghinolfi D, Ducci J, Carrai P, Petruccelli S, Biancofiore G.

Immune monitoring of a child with autoimmune hepatitis and type 1 diabetes during COVID-19 infection

Yuksel M, Akturk H, Arikan C.

Metabolic dysfunction associated fatty liver disease increases risk of severe Covid-19

Sharma P, Kumar A.

COVID 19: Management of Decompensated Cirrhosis and Liver Transplant Recipients

Rosenblatt R, Verna EC.

Chronic Liver Disease and COVID-19: Alcohol Use Disorder/Alcohol-Associated Liver Disease, Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Autoimmune Liver Disease, and Compensated Cirrhosis

Kushner T, Cafardi J.

Telemedicine and Telehepatology During the COVID-19 Pandemic

Fix OK, Serper M.

Resuming liver transplantation amid the COVID-19 pandemic

Lembach H, Hann A, McKay SC, Hartog H, Vasanth S, El-Dalil P, Murphy N, Snelson K, Patel JK, Isaac JL, Armstrong MJ, Ferguson J, Holt A, Bennett D, Sharp I, Cockwell P, Mirza DF, Isaac JR, Perera MTPR.

Risk of hepatic failure in COVID-19 patients. A systematic review and meta-analysis

Samidoust P, Samidoust A, Samadani AA, Khoshdoz S.

Intestinal ischemia in the COVID-19 era

Norsa L, Valle C, Morotti D, Andrea BP, Indriolo A, Aurelio S.

COVID-19 in a Patient with Liver Cirrhosis

Kreivenaite E, Gedgaudas R, Valantiene I, Mickiene A, Kupcinskas J.

Abnormal Liver Function Tests of Patients with Coronavirus Disease 2019 in Mainland China: A Systematic Review and Meta- Analysis

Xin S, Xu J, Yu Y.

Clinical Insights for Gastroenterology and Hepatology Providers during the COVID-19 Pandemic

Gheorghe C.

Telemedicine is a useful tool to deliver care to patients with Amyotrophic Lateral Sclerosis during COVID-19 pandemic: results from Southern Italy

Capozzo R, Zoccolella S, Musio M, Barone R, Accogli M, Logroscino G.

COVID-19 and the liver-related deaths to come

Pawlotsky JM.

Will the COVID-19 pandemic affect HCV disease burden?

Kondili LA, Marcellusi A, Ryder S, Craxì A.

Screening for active COVID-19 infection prior to biologic therapy in IBD patients: Let's not increase our uncertainty without reducing our concerns

Festa S, Aratari A, De Biasio F, Fascì-Spurio F, Papi C.

Fecal Calprotectin and RT-PCR from both nasopharyngeal swab and stool samples prior to treatment decision in IBD patients during CoVID-19 outbreak

Younes C.

High rates of 30-day mortality in patients with cirrhosis and COVID-19

Iavarone M, D'Ambrosio R, Soria A, Triolo M, Pugliese N, Del Poggio P, Perricone G, Massironi S, Spinetti A, Buscarini E, Viganò M, Carriero C, Fagiuoli S, Aghemo A, Belli LS, Lucà M, Pedaci M, Rimondi A, Rumi MG, Invernizzi P, Bonfanti P, Lampertico P.

Abnormal liver function tests predict transfer to intensive care unit and death in COVID-19

Piano S, Dalbeni A, Vettore E, Benfaremo D, Mattioli M, Gambino CG, Framba V, Cerruti L, Mantovani A, Martini A, Luchetti MM, Serra R, Cattelan A, Vettor R, Angeli P; COVID-LIVER study group.

A letter of solidarity during the COVID-19 Pandemic

Lazarus JV, Negro F, El-Sayed M, Colombo M.

Hepatocellular Carcinoma (HCC) in the COVID-19 era: Primetime for Stereotactic Body Radiotherapy and a lesson for the future?

Scorsetti M, Goodman KA, Seong J, Loi M, Huguet F, Dawson LA.

Aspartate aminotransferase: a prognostic marker rather than a specific liver injury marker in COVID-19

Li G.

Telephone-based postoperative surveillance protocol for hepatobiliary cancer during the COVID-19 outbreak

Russolillo N, Sperti E, Ferrero A.

Low incidence of COVID-19 in children and adolescent post-liver transplant at a Latin American reference center

Tannuri U, Tannuri ACA, Cordon MNA, Miyatani HT.

The COVID-19 pandemic: Clinical practice advice for gastroenterologists, hepatologists, and liver transplant specialists

Kabaçam G, Dayangaç M, Üçbilek E, Erçin CN, Günsar F, Akyıldız M, Akarsu M, Demir M, Kaymakoğlu S, Karasu Z, İdilman R.

Coronavirus Disease (COVID-19) in Kidney and Liver Transplant Patients: A Single-Center Experience

Akdur A, Karakaya E, Ayvazoglu Soy EH, Alshalabi O, Kirnap M, Arslan H, Ulubay G, Hekimoglu K, Moray G, Haberal M.

After COVID-19, green investment must deliver jobs to get political traction

Hanna R, Xu Y, Victor DG.

Between Fear and Courage: Attitudes, Beliefs, and Behavior of Liver Transplantation Recipients and Waiting List Candidates during the COVID-19 Pandemic

Reuken PA, Rauchfuss F, Albers S, Settmacher U, Trautwein C, Bruns T, Stallmach A.

Drug-Induced Liver Injury and COVID-19 Infection: The Rules Remain the Same

Olry A, Meunier L, Délire B, Larrey D, Horsmans Y, Le Louët H.

A web-based group treatment for patients with alcoholic liver diseases at the time of the COVID-19 pandemic

Bossi MM, Tufoni M, Zaccherini G, Antognoli A, Domenicali M, Caraceni P.

Management of primary hepatic malignancies during the COVID-19 pandemic: recommendations for risk mitigation from a multidisciplinary perspective

Barry A, Apisarnthanarax S, O'Kane GM, Sapisochin G, Beecroft R, Salem R, Yoon SM, Lim YS, Bridgewater J, Davidson B, Scorsetti M, Solbiati L, Diehl A, Schuffenegger PM, Sham JG, Cavallucci D, Galvin Z, Dawson LA, Hawkins MA.

Clinical characteristics of coronavirus disease (COVID-19) patients with gastrointestinal symptoms: A report of 164 cases

Zhang H, Liao YS, Gong J, Liu J, Xia X, Zhang H.

Impact of COVID-19 outbreak on clinical practice and training of young gastroenterologists: A European survey

Marasco G, Nardone OM, Maida M, Boskoski I, Pastorelli L, Scaldaferri F; Italian Association of Young Gastroenterologist and Endoscopist (AGGEI).

Hepatic consequences of COVID-19 infection. Lapping or biting?

Portincasa P, Krawczyk M, Machill A, Lammert F, Di Ciaula A.

Pattern of liver injury in adult patients with COVID-19: a retrospective analysis of 105 patients

Wang Q, Zhao H, Liu LG, Wang YB, Zhang T, Li MH, Xu YL, Gao GJ, Xiong HF, Fan Y, Cao Y, Ding R, Wang JJ, Cheng C, Xie W.

Living donor liver transplants for sick recipients during COVID-19 pandemic- An experience from a tertiary center in India

Verma S, Aleen Agarwal S, Chikkala BR, Dey R, Singh S, Varma S, Yadav V, Das D, Goyal S, Pandey VK, Nasa V, Madan K, Shweta S, Tarai B, Gupta S.

Detrimental effects of metabolic dysfunction-associated fatty liver disease and increased neutrophil-to-lymphocyte ratio on severity of COVID-19

Targher G, Mantovani A, Byrne CD, Wang XB, Yan HD, Sun QF, Pan KH, Zheng KI, Chen YP, Eslam M, George J, Zheng MH.

The use of Whatsapp(‚ìá) as a way to deliver plastic surgery teaching during the COVID-19 pandemic

Hughes BA, Stallard J, West CC.

COVID-19 in liver transplant recipients: preliminary data from the ELITA/ELTR registry

Belli LS, Duvoux C, Karam V, Adam R, Cuervas-Mons V, Pasulo L, Loinaz C, Invernizzi F, Patrono D, Bhoori S, Ciccarelli O, Morelli MC, Castells L, Lopez-Lopez V, Conti S, Fondevila C, Polak W.

Clinical implications of COVID-19 in patients with chronic liver disease and liver tumor

Gambato M, Burra P.

SARS-CoV-2: is the liver merely a bystander to severe disease?

Bangash MN, Patel JM, Parekh D, Murphy N, Brown RM, Elsharkawy AM, Mehta G, Armstrong MJ, Neil D.

COVID-19 Infection in Early Post-Operative Period after Liver Transplantation

Massoumi H, Rocca J, Frager S, Kinkhabwala M.

Inverse association between chronic hepatitis B infection and COVID-19: immune-exhaustion or coincidence?

Anugwom CM, Aby ES, Debes JD.

Kinetic patterns of liver enzyme elevation with COVID-19 in the USA

Da BL, Mitchell RA, Lee BT, Perumalswami P, Im GY, Agarwal R, Schiano TD, Dieterich D, Saberi B.

Coronavirus Disease 2019 in an Orthotopic Liver Transplant Recipient Living with Human Immunodeficiency Virus

Modi AR, Koval CE, Taege AJ, Modaresi Esfeh J, Eghtesad B, Menon KVN, Quintini C, Miller C.

One world, one pandemic, many guidelines: management of liver diseases during COVID-19

Bollipo S, Kapuria D, Rabiee A, Ben-Yakov G, Lui RN, Lee HW, Kumar G, Siau K, Turnes J, Dhanasekaran R.

Lipase Elevation in Patients With COVID-19

McNabb-Baltar J, Jin DX, Grover AS, Redd WD, Zhou JC, Hathorn KE, McCarty TR, Bazarbashi AN, Shen L, Chan WW.

Abnormal liver tests in patients hospitalized with Coronavirus disease 2019: should we worry?

Meszaros M, Meunier L, Morquin D, Klouche K, Fesler P, Malezieux E, Makinson A, le Moing V, Reynes J, Pageaux GP.

COVID emergency: an opportunity to increase the interaction between hepatologist and primary care physician

Casella G, Ingravalle F, Ingravalle A, Monti C, Bonetti F, Limonta A.

Recovery from COVID-19 following Hepatitis C, Human Immunodeficiency Virus Infection and Liver Transplantation

Müller H, Kniepeiss D, Stauber R, Schrem H, Rauter M, Krause R, Schemmer P.

Clinical decision support tool and rapid point-of-care platform for determining disease severity in patients with COVID-19

McRae MP, Simmons GW, Christodoulides NJ, Lu Z, Kang SK, Fenyo D, Alcorn T, Dapkins IP, Sharif I, Vurmaz D, Modak SS, Srinivasan K, Warhadpande S, Shrivastav R, McDevitt JT.

Managing Acute Portal Hypertensive Gastropathy Bleed During the Time of COVID-19 Pandemic: Novelty or Necessity?

Philips CA, Kumbar S, Ahamed R, Augustine P.

Synthesis of Liver Associations Recommendations for Hepatology and Liver Transplant Care During the COVID-19 Pandemic

Lau G, Ward JW.

Elevated serum aspartate aminotransferase level identifies patients with coronavirus disease 2019 and predicts the length of hospital stay

Gu X, Li X, An X, Yang S, Wu S, Yang X, Wang H.

SARS-CoV-2 Infection and the Liver

Morgan K, Samuel K, Vandeputte M, Hayes PC, Plevris JN.

Oxford Royal College of General Practitioners Clinical Informatics Digital Hub: Rapid innovation to deliver extended COVID-19 surveillance and trial platforms

de Lusignan S, Jones N, Dorward J, Byford R, Liyanage H, Briggs J, Ferreira F, Akinyemi O, Amirthalingam G, Bates C, Lopez Bernal J, Dabrera G, Eavis A, Elliot AJ, Feher M, Krajenbrink E, Hoang U, Howsam G, Leach J, Okusi C, Nicholson B, Nieri P, Sherlock J, Smith G, Thomas M, Wood I, Zambon M, Parry J, O'Hanlon S, Joy M, Butler C, Marshall M, Hobbs FR.

Liver Enzyme Elevation in Coronavirus Disease 2019: A Multicenter, Retrospective, Cross-Sectional Study

Hao SR, Zhang SY, Lian JS, Jin X, Ye CY, Cai H, Zhang XL, Hu JH, Zheng L, Zhang YM, Jia HY, Yu GD, Wang XY, Gu JQ, Lu YF, Yu XP, Yu L, Xiang DR, Ye CY, Jin CL, Qiu YQ, Li LJ, Sheng JF, Liang TB, Yang YD.

Atypical presentations of coronavirus disease 2019 in a patient with acute obstructive suppurative cholangitis

Zhai LL, Xiang F, Wang W, Wu L, Ye L, Yao LC, Tang ZG.

Telemedicine, COVID-19 and liver diseases: Revamping remote care initiatives in hepatology

Arrese M.

Rates of symptomatic SARS-CoV-2 infection in patients with autoimmune liver diseases in Northern Italy: a telemedicine study

Rigamonti C, Cittone MG, De Benedittis C, Rizzi E, Casciaro GF, Bellan M, Sainaghi PP, Pirisi M.

First case of drug-induced liver injury associated with the use of tocilizumab in a patient with COVID-19

Muhović D, Bojović J, Bulatović A, Vukčević B, Ratković M, Lazović R, Smolović B.

Gastrointestinal and hepatic manifestations of COVID-19: A comprehensive review

Cha MH, Regueiro M, Sandhu DS.

Liver diseases in COVID-19: Etiology, treatment and prognosis

Wu J, Song S, Cao HC, Li LJ.

An updated meta-analysis of AST and ALT levels and the mortality of COVID-19 patients

Wang Y, Shi L, Wang Y, Yang H.

Reply to "Coronaviruses and immunosuppressed patients. The facts during the third epidemic"

Merli M, Perricone G, Lauterio A, Prosperi M, Travi G, Roselli E, Petrò L, De Carlis L, Belli L, Puoti M.

Markers of liver injury and clinical outcomes in COVID-19 patients: A systematic review and meta-analysis

Kunutsor SK, Laukkanen JA.

Acute Liver Injury in COVID-19: Prevalence and Association with Clinical Outcomes in a Large US Cohort

Phipps MM, Barraza LH, LaSota ED, Sobieszczyk ME, Pereira MR, Zheng EX, Fox AN, Zucker J, Verna EC.

Liver tests abnormalities in COVID-19: trick or treat?

Vespa E, Pugliese N, Piovani D, Capogreco A, Danese S, Aghemo A; Humanitas Covid-19 Task Force.

Is SARS-CoV-2 associated with liver dysfunction in COVID-19 patients?

Ali N.

Low prevalence and disease severity of COVID-19 in post liver transplant recipients - a single centre experience

Verma A, Khorsandi SE, Dolcet A, Prachalias A, Suddle A, Heaton N, Jassem W.

The potential long-term impact of the COVID-19 outbreak on patients with non-communicable diseases in Europe: consequences for healthy ageing

Palmer K, Monaco A, Kivipelto M, Onder G, Maggi S, Michel JP, Prieto R, Sykara G, Donde S.

SARS-CoV-2 related liver impairment - perception may not be the reality

Philips CA, Ahamed R, Augustine P.

An international multicentre study of protocols for liver transplantation during a pandemic: A case for quadripartite equipoise

Chew CA, Iyer SG, Chieh Kow AW, Madhavan K, Teng Wong AS, Halazun KJ, Battula N, Scalera I, Angelico R, Farid S, Buchholz BM, Rotellar F, Chi-Yan Chan A, Kim JM, Wang CC, Pitchaimuthu M, Reddy MS, Soin AS, Derosas C, Imventarza O, Isaac J, Muiesan P, Mirza DF, Bonney GK.

Prioritisation and the initiation of HCC surveillance in CHB patients: lessons to learn from the COVID-19 crisis

Zeng G, Gill US, Kennedy PTF.

Liver injury in COVID-19: The current evidence

Alqahtani SA, Schattenberg JM.

A Local Response to COVID-19 for Advanced Liver Disease: Current Model of Care, Challenges and Opportunities

Serper M, Shaked A, Olthoff KM, Hoteit M, Appolo B, Reddy KR.

Clinical practice guidance for hepatology and liver transplant providers during the COVID-19 pandemic: APASL expert panel consensus recommendations

APASL Covid-19 Task Force, Lau G, Sharma M.

Lack of genetic evidence that fatty liver disease predisposes to COVID-19

Valenti L, Jamialahmadi O, Romeo S.

COVID-19 and Liver Dysfunction: a systematic review and meta-analysis of retrospective studies

Youssef M, Hussein M, Attia AS, Elshazli R, Omar M, Zora G, Farhoud A, Elnahla A, Shihabi A, Toraih E, Fawzy M, Kandil E.

Pediatric Endoscopy in the Era of Coronavirus Disease 2019: A North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition Position Paper

Walsh CM, Fishman DS, Lerner DG; NASPGHAN Endoscopy and Procedures Committee#.

COVID-19-A Guide to Rapid Implementation of Telehealth Services: A Playbook for the Pediatric Gastroenterologist

Berg EA, Picoraro JA, Miller SD, Srinath A, Franciosi JP, Hayes CE, Farrell PR, Cole CR, LeLeiko NS.

Corona Virus Disease 2019 and Paediatric Inflammatory Bowel Diseases: Global Experience and Provisional Guidance (March 2020) from the Paediatric IBD Porto Group of European Society of Paediatric Gastroenterology, Hepatology, and Nutrition

Turner D, Huang Y, Martín-de-Carpi J, Aloi M, Focht G, Kang B, Zhou Y, Sanchez C, Kappelman MD, Uhlig HH, Pujol-Muncunill G, Ledder O, Lionetti P, Dias JA, Ruemmele FM, Russell RK; Paediatric IBD Porto group of ESPGHAN.

COVID-19 in Liver Transplant Recipients: An Initial Experience from the U.S. Epicenter

Lee BT, Perumalswami PV, Im GY, Florman S, Schiano TD.

Clinical course of COVID-19 in patients with pre-existing decompensated cirrhosis: initial report from China

Qi X, Wang J, Li X, Wang Z, Liu Y, Yang H, Li X, Shi J, Xiang H, Liu T, Kawada N, Maruyama H, Jiang Z, Wang F, Takehara T, Rockey DC, Sarin SK; COVID-Cirrhosis-CHESS Group.

Liver transplantation in the era of COVID-19

El Kassas M, Alboraie M, Al Balakosy A, Abdeen N, Afify S, Abdalgaber M, Sherief AF, Madkour A, Abdellah Ahmed M, Eltabbakh M, Salaheldin M, Wifi MN.

COVID-19 and Liver Transplantation: lessons learned from three reported cases

Gao F, Zheng KI, Gu JY, George J, Zheng MH.

Convalescent plasma: A possible treatment protocol for COVID- 19 patients suffering from diabetes or underlying liver diseases

Pawar AY, Hiray AP, Sonawane DD, Bhambar RS, Derle DV, Ahire YS.

Reply to: 'Younger patients with MAFLD are at increased risk of severe COVID-19 illness: A multicenter preliminary analysis'

Ji D, Qin E, Lau G.

SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19

Wang Y, Liu S, Liu H, Li W, Lin F, Jiang L, Li X, Xu P, Zhang L, Zhao L, Cao Y, Kang J, Yang J, Li L, Liu X, Li Y, Nie R, Mu J, Lu F, Zhao S, Lu J, Zhao J.

Hepatic complications of COVID-19 and its treatment

Tian D, Ye Q.

Metabolic associated fatty liver disease increases COVID-19 disease severity in non-diabetic patients

Gao F, Zheng KI, Wang XB, Yan HD, Sun QF, Pan KH, Wang TY, Chen YP, George J, Zheng MH.

Surgical resection for liver cancer during the COVID-19 outbreak

Triki H, Jeddou H, Boudjema K.

Clinical course and risk factors for mortality of COVID-19 patients with pre-existing cirrhosis: a multicentre cohort study

Qi X, Liu Y, Wang J, Fallowfield J, Wang J, Li X, Shi J, Pan H, Zou S, Zhang H, Chen Z, Li F, Luo Y, Mei M, Liu H, Wang Z, Li J, Yang H, Xiang H, Li X, Liu T, Zheng MH, Liu C, Huang Y, Xu D, Li X, Kang N, He Q, Gu Y, Zhang G, Shao C, Liu D, Zhang L, Li X, Kawada N, Jiang Z, Wang F, Xiong B, Takehara T, Rockey DC; COVID-Cirrhosis-CHESS Group.

COVID-19 and liver cancer clinical trials: not everything is lost

D'Alessio A, Personeni N, Pressiani T, Bozzarelli S, Smiroldo V, Simonelli M, Lleo A, Santoro A, Rimassa L.

Pancreaticobiliary Endoscopy in the COVID-19 Pandemic Era

Machicado JD, Papachristou GI, Cote GA, Wani S, Groce JR, Conwell DL, Krishna SG.

Prognosis of COVID-19 in Patients with Liver and Kidney Diseases: An Early Systematic Review and Meta-Analysis

Oyelade T, Alqahtani J, Canciani G.

Stay Strong: Aboriginal leaders deliver COVID-19 health messages

Kerrigan V, Lee AM, Ralph A, Lawton P.

The liver in times of COVID-19: What hepatologists should know

Ridruejo E, Soza A.

Redesign of a GI endoscopy unit during the COVID-19 emergency: A practical model

Cennamo V, Bassi M, Landi S, Apolito P, Ghersi S, Dabizzi E, Polifemo AM, Gizzi G, Guicciardi S, Indelicato G, Cascone C, Tovoli D, Tumietto F, Viale P, Jovine E, Repici A.

"Impact of the COVID-19 pandemic on Gastroenterology Divisions in Italy: a national survey"

Maida M, Sferrazza S, Savarino E, Ricciardiello L, Repici A, Morisco F, Furnari M, Fuccio L, Morreale GC, Vitello A, Burra P, Marchi S, Annibale B, Benedetti A, Alvaro D, Ianiro G; Italian Society of Gastroenterology (SIGE).

ANALYSIS OF PATIENTS ATTITUDE TO UNDERGO URGENT ENDOSCOPIC PROCEDURES DURING COVID-19 OUTBREAK IN ITALY

Armellini E, Repici A, Alvisi C, Dinelli M, Gambitta P, Manes G, Mutignani M, Orlando S, Radaelli F, Salerno R, Venezia G, Verna C, Penagini R, Pace F; Fast Track Endoscopy Study Group.

COVID-19 pandemic perception in adults with celiac disease: an impulse to implement the use of telemedicine: COVID-19 and CeD

Siniscalchi M, Zingone F, Savarino EV, D'Odorico A, Ciacci C.

A negative fallout of COVID-19 lockdown in Italy: life-threatening delay in the diagnosis of celiac disease

Catassi GN, Vallorani M, Cerioni F, Lionetti E, Catassi C.

COVID-19 related liver injury: call for international consensus

Ye Z, Song B.

We know liver biochemistries are elevated in COVID-19, but should we be concerned?

Bloom PP, Pasricha TS, Viveiros K.

No Need of Transforming Gastroenterology Units to COVID Units at the Time of SARS-COV2 Infection - A Single-Center Analysis from Northern Italy

Zingone F, Casadei C, Farinati F, Savarino E.

The liver injury and gastrointestinal symptoms in patients with Coronavirus Disease 19: A systematic review and meta-analysis

Wang H, Qiu P, Liu J, Wang F, Zhao Q.

COVID-19 epidemic: Proposed alternatives in the management of digestive cancers: A French intergroup clinical point of view (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR)

Di Fiore F, Bouché O, Lepage C, Sefrioui D, Gangloff A, Schwarz L, Tuech JJ, Aparicio T, Lecomte T, Boulagnon-Rombi C, Lièvre A, Manfredi S, Phelip JM, Michel P; Thésaurus National de Cancérologie Digestive (TNCD); Société Nationale Française de Gastroentérologie (SNFGE); Fédération Francophone de Cancérologie Digestive (FFCD); Groupe Coopérateur multidisciplinaire en Oncologie (GERCOR); Fédération Nationale des Centres de Lutte Contre le Cancer (UNICANCER); Société Française de

Management of Hepatocellular Cancer in the time of SARS-CoV-2.

Sharma R, Pinato DJ.

Liver Biochemistries in Hospitalized Patients With COVID-19.

Bloom PP, Meyerowitz EA, Reinus Z, Daidone M, Gustafson J, Kim AY, Schaefer E, Chung RT.

Risk of severe illness from COVID-19 in patients with metabolic dysfunction-associated fatty liver disease and increased fibrosis scores.

Targher G, Mantovani A, Byrne CD, Wang XB, Yan HD, Sun QF, Pan KH, Zheng KI, Chen YP, Eslam M, George J, Zheng MH.

Health status of patients with Autoimmune Liver Disease during SARS-CoV-2 outbreak in northern Italy.

Coronavirus Disease 2019 and Viral Hepatitis coinfection: Provide guidelines for integrated screening and treatment.

Odjidja EN, Longo VL, Rizzatti G, Bandoh S.

Diagnostic Delay During the COVID-19 Pandemic: Liver Abscess Secondary to Acute Lithiasic Cholecystitis.

COVID-19: an overview of worldwide recommendations for management of patients with liver diseases or liver transplantation.

AGA Institute Rapid Review of the GI and Liver Manifestations of COVID-19, Meta-Analysis of International Data, and Recommendations for the Consultative Management of Patients with COVID-19.

Clinical Characteristics of COVID-19 in Patients With Liver Injury.

Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis.

Mao R, Qiu Y, He JS, Tan JY, Li XH, Liang J, Shen J, Zhu LR, Chen Y, Iacucci M, Ng SC, Ghosh S, Chen MH.

Gastrointestinal and Liver Manifestations of COVID-19.

COVID-19, MERS and SARS with Concomitant Liver Injury-Systematic Review of the Existing Literature.

Child with liver transplant recovers from COVID-19 infection. A case report.

Review article: COVID-19 and liver disease - what we know on 1st May 2020".

Garrido I, Liberal R, Macedo G.

A case of coronavirus disease 2019-infected liver transplant donor.

Hong HL, Kim SH, Choi DL, Kwon HH.

Liver injury in COVID-19: diagnosis and associated factors - authors' reply.

Lian N, Lin S, Xie H.

COVID-19 infection in patients following hepato-pancreatico-biliary intervention: An early experience.

Gastrointestinal, hepatobiliary, and pancreatic manifestations of COVID-19.

Declining Cirrhosis Hospitalizations in the Wake of the COVID-19 Pandemic: A National Cohort Study.

Gastroenterologists, Hepatologists, COVID-19 and the Use of Acetaminophen.

Reply to "Clinical characteristics of COVID-19 patients with abnormal liver tests".

Reply to: 'No evidence for an increased liver uptake of SARS-CoV-2 in metabolic associated fatty liver disease'.

Liver Stereotactic Ablative Radiotherapy: an Effective and Feasible Alternative to Surgery during the COVID-19 Pandemic.

Liver injury is associated with severe Coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of retrospective studies.

Parohan M, Yaghoubi S, Seraj A.

Preliminary Analysis of the Impact of COVID-19 Outbreak on Italian Liver Transplant Programs.

Agnes S, Andorno E, Avolio AW, Baccarani U, Carraro A, Cescon M, Cillo U, Colledan M, De Carlis L, De Simone P, De Ville De Goyet J, Di Benedetto F, Ettorre GM, Gringeri E, Gruttadauria S, Lupo LG, Mazzaferro V, Regalia E, Romagnoli R, Rossi GE, Rossi M, Spada M, et al.

Clinical Characteristics and Outcomes of COVID-19 Among Patients with Pre-Existing Liver Disease in United States: A Multi-Center Research Network Study.

[Risk of hepatitis B reactivation associated with treatment against SARS-CoV-2 (COVID-19) with corticosteroids].

The topic of COVID-19 related liver injury needs more rigorous research.

Acute on Chronic Liver Failure from Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).

Qiu H, Wander P, Bernstein D, Satapathy SK.

COVID-19 Hangover: A Rising Tide of Alcohol Use Disorder and Alcohol-Associated Liver Disease.

Da BL, Im GY, Schiano TD.

Changes in liver transplant center practice in response to COVID-19: Unmasking dramatic center-level variability.

Agopian V, Verna E, Goldberg D.

Hepatic involvement in COVID-19 patients: pathology, pathogenesis and clinical implications [Review].

Li Y, Xiao SY.

Hypertransaminasemia in the course of infection with SARS-CoV-2: Incidence and pathogenetic hypothesis.

Gastrointestinal and liver manifestations of COVID-19.

Cheong J, Bartell N, Peeraphatdit T, Mosli M, Al-Judaibi B.

Liver injury in critically ill patients with COVID-19: a case series.

Cardoso FS, Pereira R, Germano N.

No evidence for an increased liver uptake of SARS-CoV-2 in metabolic associated fatty liver disease.

Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease.

Suggestions for the care of patients with liver disease during the Coronavirus 2019 pandemic.

Liver injury in COVID-19: diagnosis and associated factors.

Ye Z, Song B.

Clinical Course of COVID-19 in a Liver Transplant Recipient on Hemodialysis and Response to Tocilizumab Therapy: A Case Report.

Hammami MB, Garibaldi B, Shah P, Liu G, Jain T, Chen PH, Kim AK, Avdic E, Petty B, Strout S, Fine DM, Niranjan-Azadi A, Garneau WM, Cameron AM, Monroy Trujillo JM, Gurakar A, Avery R.

Longitudinal association between markers of liver injury and mortality in COVID-19 in China.

Lei F, Liu YM, Zhou F, Qin JJ, Zhang P, Zhu L, Zhang XJ, Cai J, Lin L, Ouyang S, Wang X, Yang C, Cheng X, Liu W, Li H, Xie J, Wu B, Luo H, Xiao F, Chen J, Tao L, Cheng G, et al.

SARS-CoV-2 virus and liver expression of host receptors: Putative mechanisms of liver involvement in COVID-19.

Pirola CJ, Sookoian S.

Chapter of Gastroenterologists professional guidance for management of patients with liver disease in Singapore during the COVID-19 pandemic.

Chang JPE, Wong YJ, Yang WL, Lim KBL, Tan PS, Ho GH, Yip BCH, Li JW, Chong CH, Ong DEH, Chua TS, Vu CKF, Gwee KA, Ang TL, Tan CK.

Chapter of Gastroenterologists professional guidance for management of patients with liver disease in Singapore during the COVID-19 pandemic.

Chang JPE, Wong YJ, Yang WL, Lim KBL, Tan PS, Ho GH, Yip BCH, Li JW, Chong CH, Ong DEH, Chua TS, Vu CKF, Gwee KA, Ang TL, Tan CK.

Clinical characteristics of COVID-19 patients with abnormal liver tests.

COVID-19 and ACE2 in the liver and gastrointestinal tract: Putative biological explanations of sexual dimorphism.

Author response to Letter to the Editor "Liver impairment associated with disease progression in COVID-19 patients".

Zhang Y, Liu L, Zhao Q.

How to guarantee liver transplantation in the north of Italy during the COVID-19 pandemic. A sound transplant protection strategy.

Lauterio A, De Carlis R, Belli L, Fumagalli R, De Carlis L.

[Management of gastrointestinal and hepatic diseases during the COVID-19 outbreak].

Restellini S, Buyse S, Godat S, Goossens N, Maillard MH.

The clinical manifestations and management of COVID-19-related liver injury.

Saudi association for the study of liver diseases and transplantation position statement on liver transplantation during the COVID-19 pandemic.

Determining risk factors for mortality in liver transplant patients with COVID-19.

ACE2 Expression in Pancreas May Cause Pancreatic Damage After SARS-CoV-2 Infection.

Liu F, Long X, Zhang B, Zhang W, Chen X, Zhang Z.

HEALTH STATUS OF LIVER TRANSPLANTED PATIENTS DURING THE CORONAVIRUS OUTBREAK IN ITALY: A LARGE SINGLE CENTER EXPERIENCE FROM MILAN.

Donato MF, Invernizzi F, Lampertico P, Rossi G.

SARS-Cov-2 (human) and COVID-19: Primer 2020.

Ramakrishna G, Kumar P, Aggarwal S, Islam M, Singh R, Jagdish RK, Trehanpati N.

Management of hepatocellular carcinoma in the time of COVID-19.

Iavarone M, Sangiovanni A, Carrafiello G, Rossi G, Lampertico P.

The impact of the COVID-19 outbreak on Liver Transplantation programmes in Northern Italy.

Maggi U, De Carlis L, Yiu D, Colledan M, Regalia E, Rossi G, Angrisani M, Consonni D, Fornoni G, Piccolo G, DeFeo TM.

The impact of Covid-19 0n Head and Neck Surgery, Education and training.

Shah JP.

Coronavirus disease 2019 and prevalence of chronic liver disease: A meta-analysis.

Let's not forget our COVID-19-free cirrhotic patients!

Severe liver failure during SARS-CoV-2 infection.

Weber S, Mayerle J, Irlbeck M, Gerbes AL.

Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease.

Zheng KI, Gao F, Wang XB, Sun QF, Pan KH, Wang TY, Ma HL, Liu WY, George J, Zheng MH.

COVID-19 and viral hepatitis elimination programs: Are we stepping backward?

Karimi-Sari H, Rezaee-Zavareh MS.

Case Report: Hepatotoxicity Associated with the Use of Hydroxychloroquine in a Patient with Novel Coronavirus Disease (COVID-19).

Falcão MB, Pamplona de Góes Cavalcanti L, Filgueiras Filho NM, Antunes de Brito CA.

What Has the COVID-19 Pandemic Taught Us so Far? Addressing the Problem from a Hepatologist's Perspective.

Méndez-Sánchez N, Valencia-Rodríguez A, Qi X, Yoshida EM, Romero-Gómez M, George J, Eslam M, Abenavoli L, Xie W, Teschke R, Carrion AF, Keaveny AP.

Potential implications of COVID-19 in non-alcoholic fatty liver disease.

Prins GH, Olinga P.

Multicenter analysis of clinical characteristics and outcome of COVID-19 patients with liver injury.

Qi X, Liu C, Jiang Z, Gu Y, Zhang G, Shao C, Yue H, Chen Z, Ma B, Liu D, Zhang L, Wang J, Xu D, Lei J, Li X, Huang H, Wang Y, Liu H, Yang J, Pan H, Liu W, Wang W, et al.

Bilirubin levels in patients with mild and severe Covid-19: a pooled analysis.

Paliogiannis P, Zinellu A.

Recapitulation of SARS-CoV-2 infection and cholangiocyte damage with human liver ductal organoids.

Zhao B, Ni C, Gao R, Wang Y, Yang L, Wei J, Lv T, Liang J, Zhang Q, Xu W, Xie Y, Wang X, Yuan Z, Liang J, Zhang R, Lin X.

COVID-19 Associated Hepatitis Complicating Recent Living Donor Liver Transplantation.

Lagana SM, De Michele S, Lee MJ, Emond JC, Griesemer AD, Tulin-Silver SA, Verna EC, Martinez M, Lefkowitch JH.

COVID-19 Presenting as Acute Hepatitis.

Wander P, Epstein M, Bernstein D.

COVID-19 pandemic will have a long-lasting impact on the quality of cirrhosis care.

Tapper EB, Asrani SK.

Characteristics of Liver Tests in COVID-19 Patients.

Cai Q, Huang D, Yu H, Zhu Z, Xia Z, Su Y, Li Z, Zhou G, Gou J, Qu J, Sun Y, Liu Y, He Q, Chen J, Liu L, Xu L.

Clinical Best Practice Advice for Hepatology and Liver Transplant Providers During the COVID-19 Pandemic: AASLD Expert Panel Consensus Statement.

Fix OK, Hameed B, Fontana RJ, Kwok RM, McGuire BM, Mulligan DC, Pratt DS, Russo MW, Schilsky ML, Verna EC, Loomba R, Cohen DE, Bezerra JA, Reddy KR, Chung RT.

Liver impairment associated with disease progression in COVID-19 patients.

Chen P, Lei J, Wu Y, Liu G, Zhou B.

A Promising Anti-Cytokine-Storm Targeted Therapy for COVID-19: The Artificial-Liver Blood-Purification System.

Zhang Y, Yu L, Tang L, Zhu M, Jin Y, Wang Z, Li L.

Covid-19 and cancer patients: Choosing wisely is the key.

Cannizzaro R, Puglisi F.

Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper.

Boettler T, Newsome PN, Mondelli MU, Maticic M, Cordero E, Cornberg M, Berg T.

A Call to Action: Novel Ways that Hepatologists Can Contribute to Patient Care During the COVID-19 Pandemic.

Bloom PP.

Clinical Features of COVID-19-Related Liver Damage.

Fan Z, Chen L, Li J, Cheng X, Jingmao Yang, Tian C, Zhang Y, Huang S, Liu Z, Cheng J.

Highlights for management of patients with Autoimmune Liver Disease during COVID-19 pandemia.

Lleo A, Invernizzi P, Lohse AW, Aghemo A, Carbone M.

COVID-19 and the liver: the perils of non-peer reviewed science in times of a pandemic.

Debes JD.

COVID-19: Thoughts and comments from a Tertiary Liver Transplant Center in France.

Tzedakis S, Jeddou H, Houssel-Debry P, Sulpice L, Boudjema K.

Chronic liver disease is not associated with severity or mortality in Coronavirus disease 2019 (COVID-19): a pooled analysis.

Lippi G, de Oliveira MHS, Henry BM.

Can Hepatitis A Vaccine Provide Protection Against COVID-19?

Sarialioglu F, Belen Apak FB, Haberal M.

COVID-19 in long-term liver transplant patients: preliminary experience from an Italian transplant centre in Lombardy.

Bhoori S, Rossi RE, Citterio D, Mazzaferro V.

Implication of non-alcoholic fatty liver diseases (NAFLD) in patients with COVID-19: a preliminary analysis.

Ji D, Qin E, Xu J, Zhang D, Cheng G, Wang Y, Lau G.

Fatal outcome in a liver transplant recipient with COVID-19.

Huang JF, Zheng KI, George J, Gao HN, Wei RN, Yan HD, Zheng MH.

Management of COVID-19 in patients after liver transplantation: Beijing working party for liver transplantation.

Liu H, He X, Wang Y, Zhou S, Zhang D, Zhu J, He Q, Zhu Z, Li G, Sun L, Wang J, Cheng G, Liu Z, Lau G.

May we deliver neuro-oncology in difficult times (e.g. COVID-19)?

Perin A, Servadei F, DiMeco F; ‘Hub and Spoke’ Lombardy Neurosurgery Group..

Challenges in paediatric inflammatory bowel diseases in the COVID-19 time.

Dipasquale V, Cucchiara S, Martinelli M, Miele E, Aloi M, Romano C.

Telemedicine in Liver Disease and Beyond: Can the COVID-19 Crisis Lead to Action?

Serper M, Cubell AW, Deleener ME, Casher TK, Rosenberg DJ, Whitebloom D, Rosin RM.

COVID-19 and Liver Dysfunction: Current Insights and Emergent Therapeutic Strategies.

Feng G, Zheng KI, Yan QQ, Rios RS, Targher G, Byrne CD, Poucke SV, Liu WY, Zheng MH.

Characteristics and Mechanism of Liver Injury in 2019 Coronavirus Disease.

Li J, Fan JG.

[Analysis of baseline liver biochemical parameters in 324 cases with novel coronavirus pneumonia in Shanghai area].

Qian ZP, Mei X, Zhang YY, Zou Y, Zhang ZG, Zhu H, Guo HY, Liu Y, Ling Y, Zhang XY, Wang JF, Lu HZ.

Liver transplantation and COVID-19 (Coronavirus) infection: guidelines of the liver transplant Society of India (LTSI).

Saigal S, Gupta S, Sudhindran S, Goyal N, Rastogi A, Jacob M, Raja K, Ramamurthy A, Asthana S, Dhiman RK, Singh B, Perumalla R, Malik A, Shanmugham N, Soin AS.

COVID-19 and drug-induced liver injury: a problem of plenty or a petty point?

Boeckmans J, Rodrigues RM, Demuyser T, Piérard D, Vanhaecke T, Rogiers V.

COVID-19 and liver disease.

Sun J, Aghemo A, Forner A, Valenti L.

Liver transplantation in an ICU dominated by COVID-19.

Cardoso FS.

Successful Treatment of Severe COVID-19 Pneumonia in a Liver Transplant Recipient.

Bin L, Yangzhong W, Yuanyuan Z, Huibo S, Fanjun Z, Zhishui C.

Gastrointestinal and Liver Manifestations in Patients with COVID-19.

Lee IC, Huo TI, Huang YH.

Liver impairment in COVID-19 patients: a retrospective analysis of 115 cases from a single center in Wuhan city, China.

Zhang Y, Zheng L, Liu L, Zhao M, Xiao J, Zhao Q.

Clinical characteristics of non-ICU hospitalized patients with coronavirus disease 2019 and liver injury: A retrospective study.

Xie H, Zhao J, Lian N, Lin S, Xie Q, Zhuo H.

Perioperative Presentation of COVID-19 Disease in a Liver Transplant Recipient.

Qin J, Wang H, Qin X, Zhang P, Zhu L, Cai J, Yuan Y, Li H.

COVID-19 and the liver: little cause for concern.

Bangash MN, Patel J, Parekh D.

Coronaviruses and immunosuppressed patients. The facts during the third epidemic.

D'Antiga L.

Liver and Kidney Injuries in COVID-19 and Their Effects on Drug Therapy; a Letter to Editor.

Rismanbaf A, Zarei S.

A 55-Day-Old Female Infant infected with COVID 19: presenting with pneumonia, liver injury, and heart damage.

Cui Y, Tian M, Huang D, Wang X, Huang Y, Fan L, Wang L, Chen Y, Liu W, Zhang K, Wu Y, Yang Z, Tao J, Feng J, Liu K, Ye X, Wang R, Zhang X, Zha Y.

Liver injury during highly pathogenic human coronavirus infections.

Xu L, Liu J, Lu M, Yang D, Zheng X.

[Clinical characteristics and influencing factors of patients with novel coronavirus pneumonia combined with liver injury in Shaanxi region].

Yao N, Wang SN, Lian JQ, Sun YT, Zhang GF, Kang WZ, Kang W.

Liver injury in COVID-19: management and challenges.

Zhang C, Shi L, Wang FS.

[Discussion on diagnosis and treatment of hepatobiliary malignancies during the outbreak of novel coronavirus pneumonia].

Wu F, Song Y, Zeng HY, Ye F, Rong WQ, Wang LM, Wu JX.

[Treatment strategies of Budd-Chiari syndrome during the epidemic period of 2019 coronavirus disease].

Li LH, Zhang G, Dang XW, Li L.

[Preliminary study of the relationship between novel coronavirus pneumonia and liver function damage: a multicenter study].

Liu C, Jiang ZC, Shao CX, Zhang HG, Yue HM, Chen ZH, Ma BY, Liu WY, Huang HH, Yang J, Wang Y, Liu HY, Xu D, Wang JT, Yang JY, Pan HQ, Zou SQ, Li FJ, Lei JQ, Li X, He Q, Gu Y, et al.

[Exploring the mechanism of liver enzyme abnormalities in patients with novel coronavirus-infected pneumonia].

Guan GW, Gao L, Wang JW, Wen XJ, Mao TH, Peng SW, Zhang T, Chen XM, Lu FM.

[Novel coronavirus pneumonia related liver injury: etiological analysis and treatment strategy].

Hu LL, Wang WJ, Zhu QJ, Yang L.